Investigator of the Silk Road Joins Firm as a Director in Washington, D.C.
AstronauTx, the therapeutic biotechnology company, announces a partnership with Concept Life Sciences, a contract research firm, to help identify new therapies for Alzheimer's disease. The alliance will focus on identifying small molecules that are able to modulate astrocyte biology to expand AstronauTx's pipeline with new therapeutic candidates for the treatment of Alzheimer's disease.
Concept Life Sciences (CLS), headquartered in Alderley Park Cheshire, United Kingdom, offers tailor-made solutions from discovery to clinical development. CLS brings innovative and advanced solutions to the market through exceptional science and the highest level of customer service. As part of the alliance , CLS will bring not only its expertise in neurodegeneration but also its integrated drug discovery platform to AstronauTx to identify a novel therapy candidate for Alzheimer's disease.
AstronauTx was founded in March 2019 with an investment of £ 6.5m by the Dementia Discovery Fund (DDF) and subsequently won another £ 1m from the UCL Technology Fund. The partnership with Concept Life Sciences is the second collaboration in the UK that AstronauTx has started. The founding partnership with Alzheimer's Research UK's Drug Discovery Institute at University College London began last year and focuses on another aspect of astrocyte biology. Both partnerships build on the strong expertise of renowned British scientists in the field of industrial and academic drug discovery.
Dr. David Reynolds , Chief Executive Officer of AstronauTx , commented: “I am pleased to announce this alliance with Concept Life Sciences as it will allow AstronauTx to expand its research portfolio to target the most important support cells in the brain: astrocytes. Astrocytes usually make the brain's nerve cells work properly, but in diseases like Alzheimer's, they change and become harmful instead. Our partnership with Concept Life Sciences adds another approach to reverse astrocyte behavior in disease, which I hope will be very effective as we conduct clinical trials in the future. "
Dr. Mark Carnegie-Brown , President of Concept Life Sciences, commented: “I am pleased to announce the partnership with AstronauTx, through which we support the development of a pipeline for new therapies for astrocytes with our expertise in medicinal chemistry and CNS biology can. We look forward to working together as a team to accelerate the path of AstronauTx. "
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Severity: Warning
Message: count(): Parameter must be an array or an object that implements Countable
Filename: amp/news_details_amp.php
Line Number: 252
Backtrace:
File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler
File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view
File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.
media@smartmarketnews.com | sales@smartmarketnews.com
Contact Us